DeviceTalks Weekly

DeviceTalks Podcast Network

Hosted by Tom Salemi, DeviceTalks Weekly is the foundational podcast for the entire DeviceTalks Podcast Network. The series delivers weekly news, insights, and commentary from MedTech industry leaders, keeping the medical device industry in the know and inspiring medical technology professionals to build better MedTech devices and companies.

  1. hace 3 d

    Ep 298 - Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi is joined by Harith Rajagopalan, MD, PhD, co-founder and CEO of Fractyl Health. Dr. Rajagopalan explains why Fractyl shifted its focus from treating type 2 diabetes to helping former GLP-1 users maintain their weight loss with Revita, an outpatient endoscopic procedure designed to target the root causes of metabolic disease in the duodenum. He also shares new clinical data, the strategy behind Fractyl's pivotal trial, the company's commercialization plans, and why he believes metabolic endoscopy could become an entirely new category of care. This episode is brought to you by the  DeviceTalks Interventional Innovations series, July 28-30th. To register for this complimentary series, click here. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:35) - Keynote Interview - Harith Rajagopalan, MD, PhD, Co-Founder and Chief Executive Officer, Fractyl Health(00:06:26) - Starting with Back of the Napkin Idea(00:18:45) - Why patients are enthusiastic(00:24:35) - The Parallels to Renal Denervation(00:29:40) - Commercial Plans, Pivotal Trials & What's Next

    Ep 298 - Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

  2. 17 jul

    Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

    In this episode of the DeviceTalks Weekly Podcast, Managing Editor Kayleen Brown sits down with Johnson & Johnson MedTech Heart Recovery Worldwide President Devi Govender at DeviceTalks Boston. Govender shares how a deeply personal family experience shaped her mission to transform cardiovascular care. She reflects on Abiomed's integration into Johnson & Johnson, the evolution of heart recovery therapies, and why the industry must shift its mindset from treating "heart failure" to enabling "heart recovery." The discussion explores patient-centered innovation, AI, clinical evidence, and the power of combining technologies, data, and advocacy to redefine the future of cardiovascular care for patients around the world. This episode is sponsored by  Freudenberg Medical. Listen for a conversation with Shane Healy, Senior Director of Technology. Visit FreudenbergMedical.com for more information. We'll kick off this episode with Newmarker's Newsmakers. Host Tom Salemi and MassDevice Editor Chris Newmarker revisit the top MedTech stories of the week: Zeta Surgical, Hologic, Medtronic, Fractyl Health, and Vicarious Surgical. --- Enjoy the show? Follow DeviceTalks Weekly on all major podcast platforms, and subscribe to YouTube.com/@DeviceTalks so you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Subscribe today at [https://devicetalks.castos.com/subscribe](https://devicetalks.castos.com/subscribe). Chapters (00:09:10) - Zeta wins FDA clearance for TMS robotic stereotactic system(00:13:01) - Private equity firms reportedly set $4B price on Hologic Surgical unit(00:15:03) - Medtronic, FDA pick up legal victories in spinal cord stimulator suits(00:16:20) - Fractyl Health says its single-catheter treatment maintained most GLP-1 weight loss(00:22:17) - Vicarious Surgical's board wants to shut down and liquidate the robotics developer

    Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

  3. 10 jul

    Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

    In this episode of DeviceTalks Weekly, Host Tom explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. The conversation goes well beyond robotics. Fonseca explains why XCATH hires for humility as much as talent, how a culture of relentless experimentation and "carefrontation" fuels innovation, and why great MedTech companies are built by teams, not lone geniuses.  You'll also hear the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday."  Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of robotic intervention, and why expanding access—not simply advancing technology—is the company's ultimate goal.  MassDevice Editor Chris Newmarker returns to deliver this episode’s Newmarker’s Newsmakers – MDUFA, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences, and Johnson & Johnson MedTech.  ***  Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.  Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:08:36) - FDA releases draft MDUFA VI agreement outlining proposed legislation and program changes(00:12:50) - Resmed to sell MatrixCare software business to private equity firm for $490M/ GTCR to divest Biosurgery unit of Corza Medical(00:15:58) - Medtronic’s chief sustainability officer is departing(00:17:55) - Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences(00:19:56) - Johnson & Johnson wins FDA approval for ThermoCool SmartTouch dual-energy ablation system

    Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

  4. 26 jun

    Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse

    In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi is reassured by his conversation with Joe Catanese, CEO of Calyxo, a urology startup that has developed a system designed to simplify kidney stone removal. Catanese previously helped build Neotract, a urology startup that was acquired by Teleflex for more than $1 billion. Now, he's leading another potential gamechanger and may have his sights set on an IPO. Speaking of gamechangers, HistoSonics continues to shatter fundraising expectations. The company recently completed a financing round that valued it at $3.75 billion. In this week's FOMO interview, HistoSonics President and CEO Mike Blue speaks with MassDevice Editor Chris Newmarker during a keynote conversation at DeviceTalks Minnesota. In this excerpt, Blue reflects on the company's first major fundraising round, which attracted high-profile investors including Jeff Bezos and Peter Thiel, and shares his perspective on just how large the opportunity for histotripsy could become. But first, Tom and Jim Hammerand, managing editor of Medical Design & Outsourcing, discuss AI—or LLMs, or whatever term you prefer. Is the hype beginning to fade? And what should the industry make of the recent announcement from Midjourney Medical? *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:29) - AI Talk with Jim Hammerand, managing editor, Medical Design & Outsourcing(00:24:46) - DeviceTalks Minnesota interview excerpt - Mike Blue, CEO and President, Histosonics(00:41:44) - Keynote Interview with Joe Catanese, CEO and President, Calyxo

    Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse

  5. 19 jun

    Ep 294 - Reeve Stoffer Explains Why a Reset Might Have Been the Best Thing for Recor Medical and Renal Denervation

    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi visits his MedTech happy place — renal denervation — with Recor Medical COO Helen Reeve Stoffer. Reeve Stoffer joined the company shortly before the bottom fell out of the renal denervation market in 2014. This interview picks up from that point and follows Recor's pursuit of FDA approval to where denervation technology may be applied next. This week’s FOMO features a portion of a keynote interview with Manny Villafaña, MedTech legend and CEO of Medical 21. The conversation took place at DeviceTalks Minnesota and focuses on the dream that saved St. Jude Medical. Skyler Rivera, associate editor of MassDevice, gives us a preview of her upcoming feature in Medical Design & Outsourcing magazine on the race to provide telesurgery capabilities to surgical robotic systems. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:42) - Associate Editor Skyler Rivera's path the MedTech (and MassDevice)(00:06:00) - MDO covers the race for robotic telesurgery platforms in stroke(00:11:12) - Rivera reviews the race leaders(00:16:30) - FOMO Studio - Manny Villafana, MedTech Legend and CEO of Medical 21(00:28:19) - Keynote Interview - Helen Reeve Stoffer, COO, Recor Medical

    Ep 294 - Reeve Stoffer Explains Why a Reset Might Have Been the Best Thing for Recor Medical and Renal Denervation

  6. 12 jun

    Ep 293 - Intuitive's Hutton on Why the Surgical Robotics Leader Is Taking Aim at Cardiac Surgery Again

    In this episode, Host Tom Salemi is joined by Darla Hutton, Intuitive’s global vice president of cardiac surgery, to discuss the surgical robotics giant’s return to cardiac surgery. Intuitive famously aimed for the heart at its outset but pivoted when cardiac surgery proved too complicated. Today, heart patients and surgeons are pushing for minimally invasive procedures, and Hutton, a former cardiac surgery OR nurse, has been tapped to lead the company’s push into an increasingly competitive specialty. But first, Harmonic Drive’s Bill Frey, regional sales engineer, joins us in the FOMO Studio. Go to HarmonicDrive.net for more information. Filling in for MassDevice’s Chris Newmarker, Senior Editor Sean Whooley wraps up the five biggest stories to come out of the American Diabetes Association meeting — Abbott, Senseonics, Sequel, Dexcom, and Insulet. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:43) - Abbott studies reinforce DKA opportunity following dual sensor milestone(00:07:13) - Senseonics study supports Eversense 365 CGM with automated insulin delivery tech(00:09:20) - Sequel Med Tech data supports twiist automated insulin delivery in type 2 diabetes(00:11:18) - Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes(00:13:01) - Insulet data backs Omnipod 6, fully closed-loop AID systems(00:16:29) - FOMO Studio - Bill Frey, regional sales engineer, Harmonic Drive(00:27:14) - Keynote Interview - Darla Hutton, Global Vice President, Cardiac Surgery Intuitive

    Ep 293 - Intuitive's Hutton on Why the Surgical Robotics Leader Is Taking Aim at Cardiac Surgery Again

  7. 5 jun

    Ep 292 - Lisa Earnhardt on Abbott’s Innovation Strategy and the Future of Patient-Centered Care

    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Lisa Earnhardt, Executive Vice President and Group, President, Medical Devices, Abbott. Earnhardt shared her views on Abbott’s advances in electrophysiology, pacemakers, and other technologies in this interview, which was conducted at DeviceTalks Minnesota. In our sponsor interview ATL Medical CEO Jim Fitzgerald unpacks the meaning of its Manufacturing for Life philosophy with Managing Editor Kayleen Brown. For more information go to www.ATLMedical.com. To find the blog mentioned in the interview, go here.  But we’ll start off with MassDevice Editor Chris Newmarker with this week’s Newsmakers – Philips, Disney, Neurovalens, Edwards, Insulet and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:00) - Philips, Disney partner to improve MRI experience for children(00:09:40) - Neurovalens earns FDA nod for neuromod for PTSD(00:12:55) - Edwards gets FDA nod for Triformis Resilia surgical tricuspid valve replacement(00:14:22) - Insulet initiates another Omnipod 5 recall affecting 7 million devices including some Dash, Eros systems(00:17:01) - Medtronic sees best revenue growth in 10 years, but overall Q4 mixed

    Ep 292 - Lisa Earnhardt on Abbott’s Innovation Strategy and the Future of Patient-Centered Care

  8. 30 may

    Ep 291 - DeviceTalks Boston Wrap Up with the Editors (and Many Special Guests!)

    In this episode, the editorial team shares their highlights and lessons from two great days at DeviceTalks Boston. Tom Salemi, Kayleen Brown, Chris Newmarker, Jim Hammerand, Sean Whooley and Skyler Rivera highlighted discussions on new technologies, personal stories, Boston’s ecosystem, and the power of MedTech. Joining them on the panel were special guests Saul Marquez of the Outcomes Rocket, Etienne Nichols of Greenlight Guru and Holly Scott of The Mullings Group.   3:51 – Happy Birthday Kayleen Brown! 5:13 – MassDevice Executive Editor Chris Newmarker – Power of the Personal Story 9:25 - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism 11:10 -Associate Editor Skyler Rivera – Women in MedTech breakfast 14:05 – DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script 17:28 - MDO Managing Editor Jim Hammerand – News Team Assembled! 20:10 – Saul Marquez, Outcomes Rocket – Importance of Conferences 24:16 – Etienne Nichols, Greenlight Guru – Why Making a Difference Matters 28:22 – 32:10 – Tom Salem – We Must Pay it Forward, New MedTech modalities   ***   Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.     Chapters (00:03:51) - Happy Birthday Kayleen Brown!(00:05:13) - MassDevice Executive Editor Chris Newmarker – Power of the Personal Story(00:09:25) - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism(00:11:10) - Associate Editor Skyler Rivera – Women in MedTech breakfast(00:14:05) - DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script(00:17:28) - MDO Managing Editor Jim Hammerand – News Team Assembled!(00:20:10) - Saul Marquez, Outcomes Rocket – Importance of Conferences(00:26:16) - Etienne Nichols, Greenlight Guru – Why Making a Difference Matters(00:28:22) - Holly Scott, Senior Partner, The Mullings Group – Serendipity and MedTech Innovators(00:32:10) - Tom Salemi – We Must Pay it Forward, New MedTech modalities

    Ep 291 - DeviceTalks Boston Wrap Up with the Editors (and Many Special Guests!)
Ver todo (298)

Información

Hosted by Tom Salemi, DeviceTalks Weekly is the foundational podcast for the entire DeviceTalks Podcast Network. The series delivers weekly news, insights, and commentary from MedTech industry leaders, keeping the medical device industry in the know and inspiring medical technology professionals to build better MedTech devices and companies.

Ficha técnica

  • Creado por
    DeviceTalks Podcast Network
  • Años en activo
    2025 - 2026
  • Episodios
    298
  • Clasificación
    Apto
  • Derechos de autor
    © 2025
  • Sitio web del podcast
    DeviceTalks Weekly
  • Proveedor

Quizá también te guste